UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of bioscience and bioengineering, ISSN 1389-1723, 10/2018, Volume 126, Issue 4, pp. 522 - 526
AlphaLISA | Myasthenia gravis | Antibody screening | Nicotinic acetylcholine receptor | Membrane proteins | Food Science & Technology | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Bungarotoxins - immunology | Receptors, Nicotinic - immunology | Immunoassay - instrumentation | Humans | Receptors, Nicotinic - analysis | Antibodies - analysis | Antibodies - immunology | Immunoassay - methods | Bungarotoxins - analysis | Antigens | Immunoglobulin G | Therapeutics | Homeopathy | Materia medica and therapeutics | Index Medicus
Journal Article
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 09/2013, Volume 84, Issue 9, pp. 989 - 994
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Red-Cell Aplasia, Pure - complications | Immunologic Deficiency Syndromes - pathology | Red-Cell Aplasia, Pure - physiopathology | Myocarditis - complications | Humans | Limbic Encephalitis - complications | Myasthenia Gravis - diagnosis | Myasthenia Gravis - etiology | Alopecia Areata - complications | Taste Disorders - etiology | Thymus Neoplasms - complications | Isaacs Syndrome - physiopathology | Alopecia Areata - physiopathology | Thymus Neoplasms - pathology | Isaacs Syndrome - complications | Immunologic Deficiency Syndromes - immunology | Thymoma - pathology | Thymoma - complications | Limbic Encephalitis - physiopathology | Myasthenia Gravis - pathology | Symptomatology | Control | Myasthenia gravis | Thymoma | Diagnostic errors | Diagnosis | Research | Encephalitis | Spinal cord | Immunoglobulins | Disease | Pathogenesis | Cloning | Radiation therapy | Quality of life | Chemotherapy | Lymphocytes | Immunotherapy | Medical prognosis | Bone marrow | Muscle pain | Autoimmune diseases | Tumors | Index Medicus
Journal Article
Clinical & experimental neuroimmunology, ISSN 1759-1961, 02/2019, Volume 10, Issue 1, pp. 61 - 68
myasthenia gravis | respiratory failure | complications | claims analysis | health resources utilization | Medical research | Utilization | Myasthenia gravis | Databases | Medical care | Medicine, Experimental | Emergency medical services | Resource utilization | Parkinson's disease | Medicare | Neurodegenerative diseases | Parkinsons disease | Neuromuscular junctions | Emergency medical care | Myasthenia | Movement disorders
Journal Article
Autoimmune diseases, ISSN 2090-0430, 12/2011, Volume 2011, Issue 1, pp. 740583 - 7
Journal Article
Muscle & nerve, ISSN 0148-639X, 10/2014, Volume 50, Issue 4, pp. 493 - 500
autoimmune diseases | cohort studies | treatment | myasthenia | quality of life | Myasthenia | Treatment | Autoimmune diseases | Cohort studies | Quality of life | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Severity of Illness Index | Cross-Sectional Studies | Myasthenia Gravis - psychology | Humans | Japan | Middle Aged | Myasthenia Gravis - therapy | Male | Statistics as Topic | Myasthenia Gravis - physiopathology | Self Concept | Adult | Female | Aged | Quality of Life - psychology | Health Status | Longitudinal Studies | Corticosteroids | Myasthenia gravis | Analysis | Prednisolone | Medical treatment | Index Medicus
Journal Article
Frontiers in neurology, ISSN 1664-2295, 08/2020, Volume 11, pp. 868 - 868
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Practice guidelines (Medicine) | Care and treatment | Myasthenia gravis | myasthenia gravis | treatment strategies | logistic regression analysis | cross-sectional study | oral corticosteroids
Journal Article
Clinical & experimental neuroimmunology, ISSN 1759-1961, 11/2020, Volume 11, Issue 4, pp. 225 - 229
clinical guidelines | myasthenia gravis | diagnostic criteria | Medical research | Care and treatment | Myasthenia gravis | Corticosteroids | Medicine, Experimental | Practice guidelines (Medicine) | Prednisolone | Calcineurin | Calcineurin inhibitors | Clinical trials | CD20 antigen | Rituximab | Neuromuscular junctions | Myasthenia | Patients | Quality of life
Journal Article
Muscle & nerve, ISSN 0148-639X, 06/2017, Volume 55, Issue 6, pp. 794 - 801
treatment strategies | oral steroids | treatment target | myasthenia | Kaplan–Meier method | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Immunotherapy - methods | Humans | Japan | Middle Aged | Male | Time Factors | Statistics, Nonparametric | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Aged | Prednisolone - therapeutic use | Myasthenia Gravis - drug therapy | Cohort Studies | Medical research | Corticosteroids | Myasthenia gravis | Immunotherapy | Analysis | Medicine, Experimental | Rankings | Oral medication | Neuromuscular junctions | Myasthenia | Regression analysis | Patients | Prednisolone | Steroid hormones | Steroids | Index Medicus | Clinical Research
Journal Article
Journal of the neurological sciences, ISSN 0022-510X, 05/2020, Volume 412, pp. 116803 - 116803
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Myasthenia Gravis - complications | Disease Susceptibility | Pandemics | Coronavirus Infections - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Myasthenia Gravis - therapy | Pneumonia, Viral - drug therapy | Clinical Trials as Topic | Plasma Exchange | Vaccines | Lambert-Eaton Myasthenic Syndrome - complications | Coronavirus Infections - epidemiology | Immunoglobulins, Intravenous - therapeutic use | Pneumonia, Viral - epidemiology | Lambert-Eaton Myasthenic Syndrome - therapy | Immunotherapy | Pneumonia, Viral - complications | Betacoronavirus | Coronavirus Infections - complications | Disease Management | Myasthenia Gravis - drug therapy | Lambert-Eaton Myasthenic Syndrome - drug therapy | Immunologic Factors - therapeutic use | Index Medicus
Journal Article
Clinical & experimental neuroimmunology, ISSN 1759-1961, 11/2018, Volume 9, Issue 4, pp. 246 - 250
Journal Article
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 05/2018, Volume 89, Issue 5, pp. 513 - 517
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Neurology | Immunoglobulins | Patient satisfaction | Variance analysis | postintervention status | prednisolone | logistic regression analysis | Neuromuscular | calcineurin inhibitor | myasthenia gravis | 1506
Journal Article
European neurology, ISSN 0014-3022, 01/2011, Volume 65, Issue 1, pp. 16 - 22
Original Paper | Aggressive therapy | Corticosteroids | Myasthenia gravis | High-dose intravenous methylprednisolone | Prednisolone | Plasmapheresis | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Dose-Response Relationship, Drug | Prednisolone - administration & dosage | Humans | Myasthenia Gravis - therapy | Treatment Outcome | Retrospective Studies | Immunosuppressive Agents - administration & dosage | Methylprednisolone - administration & dosage | Index Medicus
Journal Article
Clinical & experimental neuroimmunology, ISSN 1759-1961, 11/2020, Volume 11, Issue 4, pp. 218 - 224
myasthenia gravis | immune‐related adverse events | thymoma | myocarditis | anti‐striational antibodies | Autoimmunity | Viral antibodies | Muscles | Antibodies | Myasthenia gravis | Immunoglobulins | Connectin | Thymoma | Autoantigens | Skeletal muscle | Myocarditis | Immune checkpoint | Immunotherapy | Biomarkers | Myositis | Neuromuscular junctions | Potassium channels (voltage-gated) | Myasthenia | Heart diseases
Journal Article
Clinical & experimental neuroimmunology, ISSN 1759-1961, 11/2020, Volume 11, Issue 4, pp. 209 - 217
Journal Article
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 09/2012, Volume 83, Issue 9, pp. 935 - 940
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Neurology | Biological and medical sciences | Medical sciences | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Severity of Illness Index | Receptors, Nicotinic - drug effects | Myasthenia Gravis - blood | Antibodies, Monoclonal - pharmacology | Autoantibodies - blood | Humans | Middle Aged | Rats, Inbred Lew | Rats | Male | Biomarkers - blood | Myasthenia Gravis - diagnosis | Receptors, Nicotinic - immunology | Animals | Antibodies, Monoclonal - administration & dosage | Female | Retrospective Studies | Myasthenia Gravis - immunology | Viral antibodies | Receptors | Myasthenia gravis | Physiological aspects | Antibodies | Development and progression | Acetylcholine | Research | Health aspects | Index Medicus
Journal Article